UPDATE: J.P. Morgan Initiates Coverage MedAssets on Good Market Position
In a report published Monday, J.P. Morgan analyst Gavin Weiss initiated coverage on MedAssets (NASDAQ: MDAS) with a Neutral rating and $23.00 price target.
In the report, J.P. Morgan noted, “While we like the company's positioning in both the revenue cycle and group purchasing markets, we are concerned about the impact from utilization trends on the SCM (GPO) business and the volatility experienced in the RCM business. MedAssets has a presence in ~4,200 hospitals and 122,000 non-acute care providers across the US; yet, importantly, the customer overlap of RCM and SCM businesses is just ~1,400 hospital customers, and as such there remains an opportunity for the company to expand both within and outside of its customer base.”
MedAssets closed on Friday at $21.29.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.